The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Anavex Life Sciences Corporation shares valued at $22,600 were purchased by Thomas Steffen on May 15 ’24. At $4.52 per share, Thomas Steffen acquired 5,000 shares. The insider’s holdings grew to 5,000 shares worth approximately $20850.0 following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, MISSLING CHRISTOPHER U sold 73,380 shares, netting a total of over 374,972 in proceeds. Following the sale of shares at $5.11 each, the insider now holds 1,250,210 shares.
Before that, MISSLING CHRISTOPHER U had sold 268,000 shares from its account. In a trade valued at $2,139,310, the President and CEO traded Anavex Life Sciences Corporation shares for $7.98 each. Upon closing the transaction, the insider’s holdings decreased to 268,000 shares, worth approximately $4.25 million.
As published in a research note from Cantor Fitzgerald on December 06, 2022, Anavex Life Sciences Corporation [AVXL] has been rated down from an Overweight to a Neutral and the price target has been revised to $11 from $16. Analysts at Berenberg started covering the stock with ‘”a Buy”‘ outlook in a report released in late June. As of September 23, 2021, BTIG Research has initiated its “Buy” rating for AVXL. Earlier on December 16, 2020, H.C. Wainwright resumed its rating. Their recommendation was “a Buy” for AVXL stock.
Analyzing AVXL Stock Performance
During the last five days, there has been a drop of approximately -7.33%. Over the course of the year, Anavex Life Sciences Corporation shares have dropped approximately -55.21%. Shares of the company reached a 52-week high of $6.95 on 01/02/24 and a 52-week low of $3.25 on 04/25/24. A 50-day SMA is recorded $4.28, while a 200-day SMA reached $6.13. Nevertheless, trading volume fell to 1.2 million shares from 0.8 million shares the previous day.
Support And Resistance Levels for Anavex Life Sciences Corporation (AVXL)
According to the 24-hour chart, there is a support level at 4.01, which, if violated, would cause prices to drop to 3.86. In the upper region, resistance lies at 4.42. The next price resistance is at 4.67. RSI (Relative Strength Index) is 49.82 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.17, which suggests the price will decrease in the coming days. Percent R is at 45.87%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
